256 related articles for article (PubMed ID: 37582339)
1. Proteogenomic data and resources for pan-cancer analysis.
Li Y; Dou Y; Da Veiga Leprevost F; Geffen Y; Calinawan AP; Aguet F; Akiyama Y; Anand S; Birger C; Cao S; Chaudhary R; Chilappagari P; Cieslik M; Colaprico A; Zhou DC; Day C; Domagalski MJ; Esai Selvan M; Fenyö D; Foltz SM; Francis A; Gonzalez-Robles T; Gümüş ZH; Heiman D; Holck M; Hong R; Hu Y; Jaehnig EJ; Ji J; Jiang W; Katsnelson L; Ketchum KA; Klein RJ; Lei JT; Liang WW; Liao Y; Lindgren CM; Ma W; Ma L; MacCoss MJ; Martins Rodrigues F; McKerrow W; Nguyen N; Oldroyd R; Pilozzi A; Pugliese P; Reva B; Rudnick P; Ruggles KV; Rykunov D; Savage SR; Schnaubelt M; Schraink T; Shi Z; Singhal D; Song X; Storrs E; Terekhanova NV; Thangudu RR; Thiagarajan M; Wang LB; Wang JM; Wang Y; Wen B; Wu Y; Wyczalkowski MA; Xin Y; Yao L; Yi X; Zhang H; Zhang Q; Zuhl M; Getz G; Ding L; Nesvizhskii AI; Wang P; Robles AI; Zhang B; Payne SH;
Cancer Cell; 2023 Aug; 41(8):1397-1406. PubMed ID: 37582339
[TBL] [Abstract][Full Text] [Related]
2. A proteogenomics data-driven knowledge base of human cancer.
Liao Y; Savage SR; Dou Y; Shi Z; Yi X; Jiang W; Lei JT; Zhang B
Cell Syst; 2023 Sep; 14(9):777-787.e5. PubMed ID: 37619559
[TBL] [Abstract][Full Text] [Related]
3. ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies.
Calinawan AP; Song X; Ji J; Dhanasekaran SM; Petralia F; Wang P; Reva B
Proteomics; 2020 Nov; 20(21-22):e1900359. PubMed ID: 32510176
[TBL] [Abstract][Full Text] [Related]
4. Simplified and Unified Access to Cancer Proteogenomic Data.
Lindgren CM; Adams DW; Kimball B; Boekweg H; Tayler S; Pugh SL; Payne SH
J Proteome Res; 2021 Apr; 20(4):1902-1910. PubMed ID: 33560848
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomic interrogation of cancer cell lines: an overview of the field.
Tsang O; Wong JWH
Expert Rev Proteomics; 2021 Mar; 18(3):221-232. PubMed ID: 33877947
[No Abstract] [Full Text] [Related]
6. Linking cancer genome to proteome: NCI's investment into proteogenomics.
Rivers RC; Kinsinger C; Boja ES; Hiltke T; Mesri M; Rodriguez H
Proteomics; 2014 Dec; 14(23-24):2633-6. PubMed ID: 25187343
[TBL] [Abstract][Full Text] [Related]
7. A User-Friendly Visualization Tool for Multi-Omics Data.
Huh S; Kim MS
Proteomics; 2020 Nov; 20(21-22):e2000136. PubMed ID: 32744797
[TBL] [Abstract][Full Text] [Related]
8. Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.
Wu P; Heins ZJ; Muller JT; Katsnelson L; de Bruijn I; Abeshouse AA; Schultz N; Fenyö D; Gao J
Mol Cell Proteomics; 2019 Sep; 18(9):1893-1898. PubMed ID: 31308250
[TBL] [Abstract][Full Text] [Related]
9. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
[TBL] [Abstract][Full Text] [Related]
10. Computational identification of micro-structural variations and their proteogenomic consequences in cancer.
Lin YY; Gawronski A; Hach F; Li S; Numanagic I; Sarrafi I; Mishra S; McPherson A; Collins CC; Radovich M; Tang H; Sahinalp SC
Bioinformatics; 2018 May; 34(10):1672-1681. PubMed ID: 29267878
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer proteogenomics characterization of tumor immunity.
Petralia F; Ma W; Yaron TM; Caruso FP; Tignor N; Wang JM; Charytonowicz D; Johnson JL; Huntsman EM; Marino GB; Calinawan A; Evangelista JE; Selvan ME; Chowdhury S; Rykunov D; Krek A; Song X; Turhan B; Christianson KE; Lewis DA; Deng EZ; Clarke DJB; Whiteaker JR; Kennedy JJ; Zhao L; Segura RL; Batra H; Raso MG; Parra ER; Soundararajan R; Tang X; Li Y; Yi X; Satpathy S; Wang Y; Wiznerowicz M; González-Robles TJ; Iavarone A; Gosline SJC; Reva B; Robles AI; Nesvizhskii AI; Mani DR; Gillette MA; Klein RJ; Cieslik M; Zhang B; Paulovich AG; Sebra R; Gümüş ZH; Hostetter G; Fenyö D; Omenn GS; Cantley LC; Ma'ayan A; Lazar AJ; Ceccarelli M; Wang P;
Cell; 2024 Feb; 187(5):1255-1277.e27. PubMed ID: 38359819
[TBL] [Abstract][Full Text] [Related]
12. The CPTAC Data Portal: A Resource for Cancer Proteomics Research.
Edwards NJ; Oberti M; Thangudu RR; Cai S; McGarvey PB; Jacob S; Madhavan S; Ketchum KA
J Proteome Res; 2015 Jun; 14(6):2707-13. PubMed ID: 25873244
[TBL] [Abstract][Full Text] [Related]
13. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.
Zhang Y; Chen F; Chandrashekar DS; Varambally S; Creighton CJ
Nat Commun; 2022 May; 13(1):2669. PubMed ID: 35562349
[TBL] [Abstract][Full Text] [Related]
14. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Vasaikar SV; Straub P; Wang J; Zhang B
Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
[TBL] [Abstract][Full Text] [Related]
15. Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine.
Joshi SK; Piehowski P; Liu T; Gosline SJC; McDermott JE; Druker BJ; Traer E; Tyner JW; Agarwal A; Tognon CE; Rodland KD
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():455-479. PubMed ID: 37738504
[TBL] [Abstract][Full Text] [Related]
16. Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer.
Song E; Gao Y; Wu C; Shi T; Nie S; Fillmore TL; Schepmoes AA; Gritsenko MA; Qian WJ; Smith RD; Rodland KD; Liu T
Sci Data; 2017 Jul; 4():170091. PubMed ID: 28722704
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation.
Geffen Y; Anand S; Akiyama Y; Yaron TM; Song Y; Johnson JL; Govindan A; Babur Ö; Li Y; Huntsman E; Wang LB; Birger C; Heiman DI; Zhang Q; Miller M; Maruvka YE; Haradhvala NJ; Calinawan A; Belkin S; Kerelsky A; Clauser KR; Krug K; Satpathy S; Payne SH; Mani DR; Gillette MA; Dhanasekaran SM; Thiagarajan M; Mesri M; Rodriguez H; Robles AI; Carr SA; Lazar AJ; Aguet F; Cantley LC; Ding L; Getz G;
Cell; 2023 Aug; 186(18):3945-3967.e26. PubMed ID: 37582358
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics Visualization Platform: An extensible Galaxy plug-in for multi-omics data visualization and exploration.
McGowan T; Johnson JE; Kumar P; Sajulga R; Mehta S; Jagtap PD; Griffin TJ
Gigascience; 2020 Apr; 9(4):. PubMed ID: 32236523
[TBL] [Abstract][Full Text] [Related]
19. Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors.
Groeneveld CS; Sanchez-Quiles V; Dufour F; Shi M; Dingli F; Nicolle R; Chapeaublanc E; Poullet P; Jeffery D; Krucker C; Maillé P; Vacherot F; Vordos D; Benhamou S; Lebret T; Micheau O; Zinovyev A; Loew D; Allory Y; de Reyniès A; Bernard-Pierrot I; Radvanyi F
Eur Urol; 2024 May; 85(5):483-494. PubMed ID: 37380559
[TBL] [Abstract][Full Text] [Related]
20. Advanced Proteogenomic Analysis Reveals Multiple Peptide Mutations and Complex Immunoglobulin Peptides in Colon Cancer.
Woo S; Cha SW; Bonissone S; Na S; Tabb DL; Pevzner PA; Bafna V
J Proteome Res; 2015 Sep; 14(9):3555-67. PubMed ID: 26139413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
